Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert C. Salisbury currently holds 67,707 shares of ENZON PHARMACEUTICALS INC (ENZN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert C. Salisbury has been a net buyer of ENZN stock. They have purchased $64.4K and sold $0 worth of shares.
Robert C. Salisbury's most recent insider trade was on Jul 2, 2012, when they sold 10,669 shares at $0.00 per share.
Robert C. Salisbury serves as Executive at ENZON PHARMACEUTICALS INC (ENZN). They have executed 25 insider transactions totaling $64.4K over their tenure at the company.
Robert C. Salisbury holds the position of Executive at ENZON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert C. Salisbury has shown a buying trading pattern, with $64.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert C. Salisbury was on Nov 13, 2008, when they purchased $13.1K worth of ENZN shares. This transaction involved 4,030 shares at $3.25 per share.
Robert C. Salisbury currently owns 67,707 shares of ENZON PHARMACEUTICALS INC (ENZN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert C. Salisbury's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert C. Salisbury has 25 Form 4 filings on record as an insider at ENZON PHARMACEUTICALS INC.
Set alerts for Robert C. Salisbury and 40,000+ other insiders.